Statement of Organization, Functions, and Delegations of Authority, 46677 [2016-16884]
Download as PDF
<![CDATA[
46677
Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices
OMB approval is requested for three
years. Participation is based on previous
Emergency Epidemic Investigations.
There are no costs to respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Total
number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
hours
(in hours)
Type of respondent
Form name
Emergency Epidemic Investigation
Participants.
Emergency Epidemic Investigation
Data Collection Instruments.
12,000
1
30/60
6,000
Total ...........................................
...........................................................
........................
........................
........................
6,000
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2016–16882 Filed 7–15–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 81 FR 30307–30308,
dated May 16, 2016) is amended to
reflect the reorganization of the Office of
the Director, Centers for Disease Control
and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the title and the mission and
function statements for the Office of the
Associate Director for Laboratory
Science and Safety (CAC) insert the
following:
Office of the Director (CAC1). (1)
Provides scientific, technical, and
managerial expertise and leadership in
the development and enhancement of
laboratory science and safety programs;
(2) oversees and monitors the
development, implementation, and
evaluation of the laboratory safety and
quality management programs across
CDC; (3) advises on policy,
partnerships, and issues management
matters; (4) advises on matters related to
internal and external public health
communications; (5) provides oversight
to ensure CDC compliance with
VerDate Sep<11>2014
17:52 Jul 15, 2016
Jkt 238001
regulations for select agents and toxins,
and the safe possession, use and transfer
of select agents and toxins; and (6) leads
responses to laboratory incidents and
emergencies.
Office of Laboratory Science (CACB).
(1) Provides high-level oversight and
coordination of laboratory quality and
safety training programs at all CDC
campuses; (2) develops agency-level
plans, policies, procedures and
guidelines for implementation of quality
management programs within Centers,
Institute, and Offices (CIOs); (3) assures
regulatory compliance and tracking for
CDC’s portfolio of laboratory developed
tests; and (4) provides oversight of the
catalog of laboratory safety training
activities and tracking agency-wide
progress and compliance with
laboratory safety training requirements.
Office of Laboratory Safety (CACC).
(1) Provides high-level oversight and
coordination of laboratory safety at all
CDC campuses; (2) develops and assures
effectiveness of agency-level plans,
policies, manuals and tools for
implementation of laboratory safety
standards; (3) assures regulatory
compliance for biological safety,
chemical safety, radiation safety and the
possession, use and transport of select
agents and toxins; and (4) provides
expertise and consultation for biological
safety, chemical safety and radiation
safety.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2016–16884 Filed 7–15–16; 8:45 am]
BILLING CODE 4160–18–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–16–16AVB]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
E:\FR\FM\18JYN1.SGM
18JYN1
]]>Agencies
[Federal Register Volume 81, Number 137 (Monday, July 18, 2016)]
[Notices]
[Page 46677]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16884]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 81 FR 30307-30308, dated May 16, 2016) is
amended to reflect the reorganization of the Office of the Director,
Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
After the title and the mission and function statements for the
Office of the Associate Director for Laboratory Science and Safety
(CAC) insert the following:
Office of the Director (CAC1). (1) Provides scientific, technical,
and managerial expertise and leadership in the development and
enhancement of laboratory science and safety programs; (2) oversees and
monitors the development, implementation, and evaluation of the
laboratory safety and quality management programs across CDC; (3)
advises on policy, partnerships, and issues management matters; (4)
advises on matters related to internal and external public health
communications; (5) provides oversight to ensure CDC compliance with
regulations for select agents and toxins, and the safe possession, use
and transfer of select agents and toxins; and (6) leads responses to
laboratory incidents and emergencies.
Office of Laboratory Science (CACB). (1) Provides high-level
oversight and coordination of laboratory quality and safety training
programs at all CDC campuses; (2) develops agency-level plans,
policies, procedures and guidelines for implementation of quality
management programs within Centers, Institute, and Offices (CIOs); (3)
assures regulatory compliance and tracking for CDC's portfolio of
laboratory developed tests; and (4) provides oversight of the catalog
of laboratory safety training activities and tracking agency-wide
progress and compliance with laboratory safety training requirements.
Office of Laboratory Safety (CACC). (1) Provides high-level
oversight and coordination of laboratory safety at all CDC campuses;
(2) develops and assures effectiveness of agency-level plans, policies,
manuals and tools for implementation of laboratory safety standards;
(3) assures regulatory compliance for biological safety, chemical
safety, radiation safety and the possession, use and transport of
select agents and toxins; and (4) provides expertise and consultation
for biological safety, chemical safety and radiation safety.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2016-16884 Filed 7-15-16; 8:45 am]
BILLING CODE 4160-18-P
